Short-course Radiotherapy Combined With Furoquintinib and PD-1 Monoclonal Antibody
Clinical trial NCT06014944 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06014944
- Sponsor
- Changhai Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-01
- Primary completion
- 2028-12-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.